LIVE DAY 1 ✦ September 23 - CT (Central Time)
LIVE DAY 1 ✦ September 23 - CT (Central Time)
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
- Josephine Hawkins - Associate Director, Medicaid, AstraZeneca
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
- Judd Caulfield - Lead Counsel, Oncology Business Unit, Takeda Pharmaceuticals
General metrics, pricing philosophy, interactive learning
Lifecycle Product Pricing Considerations Pre-Launch From Exclusivity Period to Landscape in Five Years Based on Indication and State
- Sharon Small - Director, Counsel Market Access, Government Pricing & Policy, Novartis
- Meena Datta - Partner, Sidley Austin LLP
Including pitfalls to avoid
The Town Hall features an open dialogue between manufacturers and States and may cover topic areas like:
Processing claims, bid cycles, best practices for different states
How manufacturers can best present their products at P&T meetings
Places of improvement for manufacturer reimbursement/processing claim process
How to work together as states and manufacturers most effectively
Addressing lengthy wait times for dispute resolution in 3rd party managed states
How to communicate with the states better so URA’s aren’t missing
Data Integrity
CLD Analysis
340B Disputes
Historical and Aged Disputes
Addressing long wait time for dispute resolution in 3rd party managed states and how to enhance this process
Rebate Credits
Discrepancies with URA Calculations
Utilization on Supplemental Invoices while Disputing the same on a federal invoice
- Ryan Bruce - Associate Director of Medicaid, AstraZeneca
- Cathy Burton-Meza - Associate Director, Government Rebates, Gilead Sciences
- Nicolette Dione, PharmD - Drug Rebate Services Manager, Gainwell Technologies
- Jodi Hettinga - Drug Rebate Specialist, Senior Professional Business Process Outsourcing, Pharmacy Benefit Management, Gainwell Technologies
Back by Popular Demand!
Join us for this deep dive workshop into the ever-changing active and pending SPTR laws from the legal and operational perspectives. Topics discussed will include:
Soup to Nuts requirements (where to go, what to do for new products etc.)
New waiver/changes/updates to TN, OR and more
Examples of reasonable assumptions – differences in terms and definitions across States
Best Practices panel with Manufacturer’s, Counsel and Consultants
Q&A
- Gregg Kasten - VP, Products and Services, ClassOne Insight
- Learn how your peers are addressing SPTR management, operations, and compliance
- Gain more understanding of best practices that you can apply in your organization
- Hear perspectives on future developments
- John McGrory - CEO, ClassOne Insight
Tracking legislation and implementing best practices at your company and scaling of efforts
Privacy hot button issues
Current litigation review
What you need to report to what states and what information you need to back it up
What manufacturers are standing against in SPTR and results
- Tiffany Frankson - Assistant General Counsel, Pricing and Access, Pfizer
- Felecia Manning - Director, Managed Markets Contracts & Government Pricing, United Therapeutics Corporation
This session describes core 340B compliance requirements for pharmaceutical manufacturers. Objectives:
- Discuss elements of the pharmaceutical pricing agreement
- Describe 340B ceiling price calculation
- Identify pricing responsibilities with HRSA and wholesalers
This session reviews leading practices for maintaining program integrity and going through the HRSA audit process. Objectives:
Outline HRSA integrity initiatives
Discuss leading practices to prepare and complete the HRSA audit process for manufacturers
Describe post-audit procedures, including implementation of a successful corrective action plan
Objectives
- Describe common 340B drug dispensing pathways in outpatient settings
- Discuss covered entity inventory management models and purchasing account setups
- Examine differences between good-faith inquiries, HRSA-approved manufacturer audits of covered entities, and covered entity self-audits
This session describes the role of the 340B Prime Vendor Program, managed by Apexus, and resources provided to manufacturers. Objectives:
- Identify resources the Prime Vendor provides to support manufacturers and the 340B community
- Discuss contracting and other services available to manufacturers
These one-on-one meetings are scheduled between manufacturers and States to discuss any issues or questions that have come up with rebates and reporting, etc.
•Alaska • Arizona • Arkansas • California • Colorado • Connecticut • DC • Delaware • Georgia • Hawaii •Idaho • Indiana • Kentucky • Louisiana • Maryland • Massachusetts •Michigan • Montana • Nebraska • New Hampshire • New Mexico •New York • North Carolina • Pennsylvania • Rhode Island • South Carolina • Tennessee • Texas •Virginia
- Nicolette Dione, PharmD - Drug Rebate Services Manager, Gainwell Technologies
- Jodi Hettinga - Drug Rebate Specialist, Senior Professional Business Process Outsourcing, Pharmacy Benefit Management, Gainwell Technologies
- Jeanine Lundeberg - Director, Pharmacy Rebate Management, Magellan Health
- Dena Karels - CPhT Lead, Manager, Rebate Dispute Management, Magellan Health
These one-on-one meetings are scheduled between manufacturers and States to discuss any issues or questions that have come up with rebates and reporting, etc.
•Alaska • Arizona • Arkansas • California • Colorado • Connecticut • DC • Delaware • Georgia • Hawaii •Idaho • Indiana • Kentucky • Louisiana • Maryland • Massachusetts •Michigan • Montana • Nebraska • New Hampshire • New Mexico •New York • North Carolina • Pennsylvania • Rhode Island • South Carolina • Tennessee • Texas •Virginia
- Nicolette Dione, PharmD - Drug Rebate Services Manager, Gainwell Technologies
- Jodi Hettinga - Drug Rebate Specialist, Senior Professional Business Process Outsourcing, Pharmacy Benefit Management, Gainwell Technologies
- Jeanine Lundeberg - Director, Pharmacy Rebate Management, Magellan Health
- Dena Karels - CPhT Lead, Manager, Rebate Dispute Management, Magellan Health